Aiello Joshua
Known title: Principal Accounting OfficerCIK: 0001960418
Associated companies
Transaction History
| OBIO | ▼ Sell | Tax Withholding | 203 | $1K | 8/26/2026 | View on chart |
| OBIO | ▼ Sell | Tax Withholding | 241 | $1K | 3/25/2026 | View on chart |
| OBIO | ▼ Sell | Tax Withholding | 241 | $1K | 1/2/2026 | View on chart |
| OBIO | ▼ Sell | Tax Withholding | 203 | $499 | 9/17/2025 | View on chart |
| OBIO | ▲ Buy | Grant | 15,000 | $0 | 8/7/2025 | View on chart |
| OBIO | ▼ Sell | Tax Withholding | 393 | $1K | 6/18/2025 | View on chart |
| OBIO | ▼ Sell | Tax Withholding | 278 | $1K | 3/26/2025 | View on chart |
| OBIO | ▲ Buy | Grant | 5,000 | $0 | 7/20/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
OBIO Shares Rise 5.2% Amid Positive Momentum
Orchestra BioMed Holdings (OBIO) shares recently increased by 5.2%, a move that some observers see as a sign of strengthening momentum. The stock currently trades within its 52-week range of $2.20 to $6.48. Analysts maintain an average price target of $12.14, suggesting a significant gap between the current market price and professional estimates.
OBIO Shares Rise 5.2% Amid Positive Momentum. Orchestra BioMed Holdings (OBIO) shares recently increased by 5.2%, a move that some observers see as a sign of strengthening momentum. The stock currently trades within its 52-week range of $2.20 to $6.48. Analysts maintain an average price target of $12.14, suggesting a significant gap between the current market price and professional estimates.